North American Rep. Office of Shenzhen
The North American Representative Office of Shenzhen, P. R. China (NAROS) is a U.S. based, business service provider representing the City of Shenzhen, China´s first Special Economic Zone. Directly sponsored by the Shenzhen Municipal Government and Invest Shenzhen, NAROS offers guidance and consultation to North American companies wishing to enter the Chinese market by means of direct investment within in the City of Shenzhen, as well as to Shenzhen-based companies looking to enter the North American market.
Mr. Paul Xu
Business Development SpecialistNurtureX
Strategy, Management and fundraising for genomic companies. Invest and help raise capital through private and public placements in the US, as well as guide company executives on Operational execution in the molecular diagnostics industry.
OcuMedic, Inc.
Replace eye drops from FREEDOM drug releasing clear contact lens corneal bandage. The device has a 7 day wear time consistent with the standard of care recall after; cataract, LASIK surgery & corneal abrasion & non infectious Uveitis. Doctor puts device on and takes it off eliminating patient compliance problems with quicker healing with drug constantly treating the target tissue. 10 granted patents with FTO legal opinion. 10 mono and combo ophthalmic Dougs tested. Completed in vivo safety study. Letter and meeting being set with the US FDA for phase 1-2 clinical in January 2021.
Mr. Keith Ignotz
President & CEOOneThree Biotech
My organization, OneThree Biotech, is a company that is dedicating our biology-driven AI expertise towards the fight against cancer. We’re combining systems biology with artificial intelligence to uncover new insights and build the next generation of drug discovery. We’ve built 14 different algorithms into our platform to provide insights across steps like target selection, compound mechanisms, toxicity and metabolism, and patient biomarkers at the beginning of the development process. This not only provides greater mechanistic insights, but also helps ensure a greater success rate for drugs entering preclinical development. Over the course of 2020 our founders have spoken at countless events like the BioData World Congress, Pharma and Patient USA, and various Reuters events culminating in our most recent accomplishment of winning Reuters' Entrepreneur Award for Health Solutions.
Mr. Abhinav Subramaniam
Strategy and Operations AssociateOneWorld Diagnostics
OneWorld Diagnostics is a German biotech company which focuses on veterinary diagnostics solutions and R&D tools and products. With our professional services and customized research solution, OneWorld Diagnostics is a trusted contract research organization specializing in diagnostic assay development and tech transfer. We are the trusted partner of the Top 5 international and Chinese pharmaceutical companies.
Our expertise is in developing research solution particularly in microbiology, molecular and immunology assay development and tech transfer in China and European markets.
Our expertise is in developing research solution particularly in microbiology, molecular and immunology assay development and tech transfer in China and European markets.
Dr. Karen Hung
CEOOtomagnetics
Otomagnetics is a biotechnology Company developing a non-invasive platform technology to deliver drugs and other therapeutic payloads to the inner and middle ear compartments, eye and skin. The link to the explainer video on the technology is provided below.
https://www.youtube.com/watch?v=1go9HYjMlFk&feature=youtu.be
https://www.youtube.com/watch?v=1go9HYjMlFk&feature=youtu.be
Mrs. Abhita Batra
CEOPanakes Partners SGRSpa
Panakes Partners is a Venture Capital investor financing early and late stage medical companies, with innovative products and great ambition teams.
Panakes invests in seed to pre-IPO rounds mainly in European companies but also in Israel and in the US.
The team provides more than capital working together with entrepreneurs to develop successful businesses as an active and well-connected investor. Panakes has a strong relationships with selected industrial partners of the sector to help companies to accelerate their development
Panakes invests in seed to pre-IPO rounds mainly in European companies but also in Israel and in the US.
The team provides more than capital working together with entrepreneurs to develop successful businesses as an active and well-connected investor. Panakes has a strong relationships with selected industrial partners of the sector to help companies to accelerate their development